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Abstract
Background—The arrhythmogenesis of ventricular myocardial ischemia has been extensively 
studied, but models of atrial ischemia in humans are lacking. This study aimed at describing the 
electrophysiological alterations induced by acute atrial ischemia secondary to atrial coronary 
branch occlusion during elective coronary angioplasty.   
Methods and Results—Clinical data, 12-lead ECG, 12-hours Holter recordings, coronary 
angiography, and serial plasma levels of high sensitivity troponin T and mid-regional proatrial 
natriuretic peptide were prospectively analyzed in 109 patients undergoing elective angioplasty 
of right or circumflex coronary arteries. Atrial coronary branches were identified and after the 
procedure patients were allocated into two groups: atrial branch occlusion (ABO, n=17) and 
atrial branch patency (non-ABO, n=92). As compared with the non-ABO, patients with ABO 
showed: a) higher incidence of periprocedural myocardial infarction (20% vs. 53%, p= 0.01); b) 
more frequent intra-atrial conduction delay (19% vs. 46%, p=0.03); c) more marked PR segment 
deviation in the Holter recordings; and d) higher incidence of atrial tachycardia (15% vs. 41%, 
p=0.02) and atrial fibrillation (0% vs. 12%, p=0.03). After adjustment by a propensity score, 
ABO was an independent predictor of periprocedural infarction (OR 3.4, CI 1.01-11.6, p<0.05) 
and atrial arrhythmias (OR 5.1, CI 1.2-20.5, p=0.02).   
Conclusions—Selective atrial coronary artery occlusion during elective PTCA is associated with 
myocardial ischemic damage, atrial arrhythmias, and intra-atrial conduction delay. Our data 
suggest that atrial ischemic episodes might be considered as a potential cause of atrial fibrillation 
in patients with chronic coronary artery disease. 
Key words: atrial coronary artery occlusion, percutaneous transluminal coronary angioplasty, 
periprocedural myocardial infarction, PR segment deviation, intra-atrial conduction delay, atrial 
fibrillation. 
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Background
As compared with the well documented arrhythmogenic potential of acute ventricular 
myocardial ischemia 1, less is known about the electrophysiological alterations induced by 
selective ischemia at the atrial myocardial level. In clinical practice, atrial myocardial ischemia 
often coexists with ischemia at the ventricular myocardium in patients with acute coronary artery 
occlusion and, therefore, the distinctive effects of ischemia at either of the two levels cannot be 
ascertained. It is accepted that the occurrence of atrial fibrillation (AF) in patients with ST-
segment elevation myocardial infarction reflects extensive myocardial ischemia involving the 
atrial chambers 2. However, a direct link between atrial myocardial ischemia and AF has been 
only demonstrated in experimental animal models submitted to selective occlusion of atrial 
coronary branches 3–6. These studies revealed that atrial ischemia induced local atrial conduction 
slowing and favored the electrical induction and maintenance of AF.  
Considering the fact that the atrial coronary branches emerge from the right and/or 
circumflex coronary arteries, percutaneous transluminal coronary angioplasty (PTCA) directed to 
these arteries may result in accidental occlusion of the atrial branches and, therefore, this event 
may emerge as a potential clinical model for the study of selective acute atrial ischemia in 
humans. Although the incidence of atrial side branch occlusion (ABO) was found about 21.5% in 
a retrospective analysis in our institution 7, the clinical and electrophysiological consequences of 
this complication have not yet been described.  
The aim of this study was to prospectively analyze the electrocardiographic changes and 
arrhythmogenic potential of selective acute atrial myocardial ischemia in humans and, moreover, 
the clinical and biochemical consequences of accidental ABO during elective PTCA. 
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Methods
Study design  
We conducted a prospective cohort study which included consecutively all patients undergoing 
elective PTCA of the right or circumflex coronary artery in our institution since December 2010 
to March 2014. The inclusion criteria were: a) presence of sinus rhythm on the admission 
electrocardiogram (ECG), b) need to deploy the stent in a coronary segment encompassing the 
exit of an atrial coronary artery, or in a close proximity (?5 mm) of the origin of an atrial branch 
assessed by Quantitative Coronary Assessment (QCA) software (Philips Allura Xper FD 10). 
The exclusion criteria were: a) patients with acute coronary syndrome, b) previous history of 
atrial arrhythmias, and c) concurrent occlusion of coronary ventricular side-branch at the end of 
PTCA. All patients had to fulfill the inclusion and none of the exclusion criteria. The study was 
approved by the Ethics committee of our institution and all patients gave written consent prior to 
the coronary intervention. 
Study protocol 
The patients were admitted to the hospital in a stable clinical condition. In all cases the clinical 
history, physical examination, 12-lead ECG, blood tests including high sensitivity cardiac 
troponin T (hs-cTnT) (Elecsys, Roche Diagnostics©), and mid-regional proatrial natriuretic 
peptide (MR-proANP) (ThermoFisher Scientific©) were collected prior and after PTCA. At the 
end of the coronary intervention, patients were allocated into two groups according to the post 
PTCA atrial branch patency. The ABO group included those patients in whom the coronary 
artery flow in the atrial branch assessed by TIMI score 8 fell from grades 2–3 to grades 0–1 after 
the procedure. The non-ABO group consisted of those patients in whom the baseline TIMI in the 
atrial branch was normal and did not change after PTCA. Cardiac rhythm was continuously 
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monitored during 12 hours in all patients starting in the catheterization laboratory immediately 
after the PTCA intervention using a Holter DigiTrak Plus Recorder (Philips Medical Systems, 
Bothell, USA).  During this recording period, the patients remained at rest in the recumbent 
position in the ward. Serial plasma levels of hs-cTnT and MR-proANP were also measured at 2-, 
4-, 8- and 12-hours after angioplasty, and the 99th reference percentile used for hs-cTnT was 14 
ng/L. A second 12-lead ECG was collected prior to hospital discharge.     
Angiographic analysis 
Coronary angiography was reviewed by two interventional cardiologists. All frames were 
calibrated with the tip of the catheter as a reference guide before contrast injection. Two 
orthogonal projections were used prior and after PTCA. In each coronary artery segment, we 
measured the luminal diameter and the percentage of stenosis using the QCA software. The 
coronary arterial blood flow was qualitatively evaluated using the TIMI score 8. We also 
evaluated the length of the coronary lesion and the plaque characteristics according to the 
American College of Cardiology/American Heart Association (ACC/AHA) classification 9. In 
each atrial coronary artery, we specifically analyzed the presence of atherosclerotic plaques, the 
maximal luminal diameter, and the TIMI flow before and after PTCA. To define the spatial 
relationship between the location of the target atherosclerotic plaques for PTCA and the site of 
origin of the atrial branch, we followed the Medina's classification 10. We also registered the type 
of vascular access, the indication for angioplasty, the characteristics of the implanted stent, and 
all technical procedures related with PTCA.  
ECG and Holter analysis 
Variables collected from the conventional ECG include the duration of the P wave, PR interval, 
and QRS complex. The ECG tracings were digitized and the parameters were measured with 
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electronic calipers (Cardio-Calipers software, Iconico©) under appropriate image magnification. 
Intra-atrial conduction delay was defined by the presence of a P wave duration ? 120 
milliseconds, usually with a bimodal or biphasic shape in leads II, III, or aVF 11. Furthermore, 
we analyzed the P wave morphology and PR segment displacement during two epochs (the first 
and last ten minutes in each 12-hour Holter recording), using signal averaging techniques to 
attain low noise level. From each epoch an averaged beat was obtained from a 3-minute block 
using conventional ensemble averaging of the normal sinus beats. Signal-averaging procedure 
and ECG delineation was performed using the software developed by the Signal Processing 
Group, Lund University, Sweden 12,13. This algorithm allows calculation of the deviation of the 
PR segment with respect to the TP segment (isoelectric line) taking a set of 20 points that are 
part of the TP-segment and selecting the median potential as reference level.   
The ECG and Holter recordings were blindly examined by two investigators. In case of 
doubt, a third senior investigator reviewed the studies.  
Statistical analysis 
Categorical variables were described by frequencies and percentages and statistical differences 
were analyzed using the ?2 test or Fisher´s exact test when any expected cell frequency was <5. 
Continuous variables were described by the mean and standard deviation and statistical 
differences were analyzed using the Student's t test in the case of a normal distribution. To 
evaluate the effect of ABO to predict the presence of myocardial infarction related with PTCA 
and atrial arrhythmias in the Holter study, a multivariable logistic regression model was 
performed adjusting for a propensity score including the covariates statistically significant at the 
univariable analysis (p value less than 0.20 as a criterion of entry into multivariable analysis). 
Periprocedural myocardial infarction was defined according to the current criteria of the third 
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universal definition of myocardial infarction 14. To assess the predictive ability of our model, we 
calculated the area under the receiver operating characteristics curve assuming a nonparametric 
distribution. A p value of less than 0.05 was considered statistically significant. For all 
calculations we used the software SPSS (IBM, 22 version). 
 
Results
From a total number of 3,306 patients submitted to PTCA between December 2010 and March 
2014 in our institution, 109 fulfilled the inclusion criteria and entered in the analysis. The flow-
chart study is shown in Figure 1.  
Clinical characteristics of the study population 
Accidental ABO after elective PTCA occurred in 17 (15.6%) out of 109 patients. Table 1 
summarizes the clinical characteristics of the study population. There were no significant clinical 
differences between the two study groups. Specifically, the prevalence of previous myocardial 
infarction and the need for PTCA or coronary bypass surgery were comparable among patients 
with and without atrial branch occlusion. Figure 2 illustrates an example of post PTCA occlusion 
of an atrial coronary artery occlusion arising from the right coronary artery.  
Angiographic and intervention procedural findings 
Atrial coronary arteries arose from both right and circumflex coronary arteries in at least 98% of 
patients. The atrial branches supplying the sinus atrial node and the atrio-ventricular node 
originated in most instances from the right coronary artery (57% and 88%, respectively). Among 
the 17 patients with occluded branches, these exited the circumflex coronary artery in 2 cases 
and the right coronary artery in 15 patients.      The average sizes of the atrial branch in the ABO 
and non-ABO group were 1.25 and 1.41 mm, respectively. There were no significant differences 
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between both groups in any of previous variables. However, the ABO group presented more 
frequently atherosclerotic plaques at the ostium of atrial branch than non-ABO group (77 vs. 
23%, p<0.01). The presence of a bifurcation lesion and a longer length of the stent were 
significantly more common in ABO patients than in the group without the loss of atrial artery. 
Table 2 shows the remaining angiographic and PTCA procedural characteristics of the study 
population. 
Plasma biomarkers 
Figure 3A illustrates the time course of plasma concentrations of hs-cTnT in both groups of 
patients. Patients with ABO depicted significantly higher values in the samples obtained after 8 
hours of PTCA, thus reflecting myocardial damage. According to these data, the incidence of 
periprocedural myocardial infarction was significantly higher in the group with ABO (53% vs. 
20%, p= 0.01). After adjustment by the propensity score including all significant variables of the 
Table 2, the occurrence of ABO was an independent predictor of periprocedural infarction (OR 
3.4, 95%CI 1.01-11.6, p<0.05).  
The time course of plasma levels of MR-proANP after coronary intervention is shown in 
the Figure 3B. In both groups the PTCA was followed by a release of the natriopeptide during 
the first 4 hours after the intervention. Moreover, both curves showed a parallel trend, with 
higher values in the ABO than in the non-ABO group, although this difference was not 
statistically significant (MR-proANP peak: 204 pmol/L vs. 164 pmol/L; p= 0.195). 
ECG and Holter findings  
As summarized in Table 3, analysis of the 12-lead ECG showed that both groups of patients had 
an increase in the duration of the P wave after PTCA, but the new onset intra-atrial conduction 
delay was almost three times more frequent in the ABO group (Figure 4A). Of notice, new ST-
 by guest on May 6, 2016http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.116.021700 
9 
segment changes or Q-waves were not observed in any case. The 12-hour Holter recording 
(Table 4) showed that ABO patients presented atrial arrhythmia and atrial fibrillation episodes 
more frequently than patients without ABO (Figure 4B). The episodes of atrial arrhythmia 
consisted of about 3 to 20 ectopic beats with a mean frequency of 125 beats per minute. The 
episodes of atrial fibrillation in the two ABO patients lasted less than 10 seconds and reverted 
spontaneously to sinus rhythm. Electrical cardioversion was not required in any patient After 
adjustment by the propensity score including the same significant variables of Table 2, ABO was 
also an independent predictor of the presence of atrial arrhythmias (OR 5.1, 95%CI 1.2-20.5, 
p=0.02). During the Holter recording, 8 patients presented self-limited episodes of monomorphic 
ventricular tachycardia (3 in the ABO group and 5 in the non-ABO group, p=0.076). However, 3 
in the ABO group and 4 in the non-ABO group have already previous history of episodes of non-
sustained monomorphic ventricular tachycardia. Signal averaging analysis revealed that patients 
with ABO had a significant PR deviation that was maximal during the first 10 minutes of the 
study and declined thereafter progressively (Figure 4C). Moreover, the amplitude of the P wave 
was smaller in patients with ABO (Figure 4D). 
 
Discussion
Main findings 
This is the first study analyzing prospectively the electrophysiological alterations induced by 
acute atrial infarction in humans. As a clinical model of atrial myocardial ischemia we recruited 
patients presenting selective occlusion of atrial coronary arterial branches during elective PTCA. 
Compared to patients with patent atrial vessels, patients with ABO presented a plasma hs-cTnT 
pattern of periprocedural myocardial infarction associated with higher incidence of interatrial 
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conduction disturbances, PR segment deviation, and episodes of atrial tachycardia and atrial 
fibrillation. 
Electrophysiological effects of atrial myocardial ischemia  
The local electrophysiological derangements induced by atrial myocardial ischemia have not 
been directly investigated in humans and only electrocardiographic abnormalities bounded to the  
morphology of the P wave and to the position of the PR segment (P-Ta segment) over the 
isoelectric line have been reported 15,16. Direct characterization of the atrial ischemic 
electrophysiological substrate has been attempted in a restricted number of experimental studies 
in animals submitted to selective ligature of atrial coronary arterial branches 3–6. In these 
experimental models mapping of local electrograms over the atrial surface revealed a significant 
slowing of local conduction in the ischemic zone creating conditions for increased inducibility 
and maintenance of atrial fibrillation 3,5. The local conduction delay will therefore explain the 
changes in the duration and shape of the P wave in our patients with atrial branch occlusion. The 
ischemic etiology of interatrial conduction disturbances was indirectly suggested in a previous 
study in 27 coronary atherosclerotic patients with established interatrial block who presented a 
higher incidence of right coronary involvement than 42 control patients without conduction delay 
17. Slowing of local conduction and propensity to reentrant arrhythmias are, on the other hand, 
classical features observed during acute ischemia at the ventricular myocardium 1. Deviation of 
the PR segment was formerly described in single case reports of atrial infarction 18 and a 
systematic analysis of the ECG patterns was later compiled by Liu et al 19. Understanding of the 
PR segment deviation is founded on the concept that local atrial action potential repolarization 
occurs at the time of the inscription of the PR segment in the ECG as denoted when simultaneous 
recording of atrial monophasic potentials and conventional ECG leads are taken in humans 20. 
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Consequently, the local ST segment elevation that is induced by atrial injury is in fact indirectly 
represented in the ECG as a displacement of the PR segment 21. The location of the atrial 
ischemic area may influence the pattern of ST segment behavior in the different ECG leads and 
ultimately, may determine the positive or negative deviation of the PR segment.  In the dog 
heart, selective injury in left atrial segments elicited positive PR deviation in leads I, aVL and 
negative displacement in leads II,III, and aVF whereas an opposite pattern was observed in dogs 
with right atrial injury 21.  
It is widely accepted that the occurrence of atrial fibrillation in patients with ST-segment 
elevation myocardial infarction denotes extensive myocardial ischemia involving the atrial 
chambers 2 but in the acute phase of myocardial infarction an associated hyperadrenergic nerve 
tone 22 or an increase of atrial filling pressures might also play a role 23. Thus a relevant 
contribution of our study is the proof of concept that atrial infarction is per se a cause of atrial 
arrhythmias in men. Considering the fact that atrial infarction is rarely recognized ante mortem, 
our data would support the assumption that clinically silent episodes of atrial coronary branch 
occlusion should be considered as a cause of atrial fibrillation in patients with chronic coronary 
artery disease. 
Accidental atrial coronary artery occlusion   
This study shows that about 15% of patients undergoing elective PTCA of the right or 
circumflex coronary arteries are at risk of presenting accidental occlusion of coronary atrial 
branches. Despite this notorious incidence, the clinical consequences of atrial branch occlusion 
have not been prospectively investigated and this complication is often disregarded in the PTCA 
procedural clinical reports. Our results are the first showing that the accidental occlusion of atrial 
branches should far from be considered an uneventful complication because it causes structural 
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myocardial damage denoted by the rise of plasma hs-cTn levels and it favors atrial 
arrhythmogenesis. Moreover, we identified the presence of atherosclerotic plaques at the ostium 
of atrial branches, the bifurcated lesions, and the need for implanting longer stents as 
independent predictors of the accidental atrial vessel occlusion. Thus, new technical measures 
aimed to protect the patency of atrial branches should be implemented in patients undergoing 
elective PTCA of right of circumflex coronary arteries, as occurred in the field of SBO 
prevention 24.  
Considerations on the model 
Due to the relatively small sample size and modest event frequencies, the results of our study 
should be interpreted cautiously.  
The accidental occlusion of an atrial coronary branch offers the opportunity to selectively 
investigate the pathophysiology of atrial myocardial ischemia provided the absence of concurrent 
ischemia at the ventricular level. Consequently, we did not include patients presenting 
simultaneous accidental occlusion of both ventricular and atrial coronary branches.
In our study, the diagnosis of atrial coronary occlusion was based on the coronary 
angiography performed just at the end of the PTCA procedure and therefore a later spontaneous 
reperfusion of the atrial vessel cannot be entirely discarded. To rule out this possibility a second 
follow-up angiography would be required but at present time, this procedure is not justified 
because the current guidelines for percutaneous coronary interventions do not take into 
consideration the accidental occlusion of atrial branches during elective PTCA. 
Since about half of our patients had suffered previous myocardial infarction, they might 
have developed collaterals in the ventricular but also possibly in the atrial myocardium. These 
circumstances could influence the size of atrial infarction resulting from the atrial branch 
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occlusion 25. However, the prevalence of previous myocardial infarction and the need for PTCA 
or coronary bypass surgery were comparable in the two groups of patients, suggesting that the 
likelihood to develop coronary collaterals would have been similar in patients with and without 
atrial coronary branch occlusion.
We studied atrial electrophysiological derangements over a 12-hour period in patients 
undergoing elective PTCA and therefore knowledge of the long-term impact of these findings 
would require further specific follow-up studies.  
 
Conclusions
As a new study model of atrial ischemic injury, we found that selective atrial coronary artery 
occlusion during elective PTCA is associated with myocardial ischemic damage, atrial 
arrhythmias, and interatrial conduction delay. These data support the assumption that atrial 
ischemic episodes might be a potential cause of atrial fibrillation in patients with chronic 
coronary artery disease. 
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Clinical Perspective 
We handled the accidental occlusion of atrial coronary arteries during elective percutaneous 
coronary intervention as a prospective clinical model for the study of the electrophysiological 
effects of acute atrial myocardial infarction. Patients with selective atrial branch occlusion 
depicted a troponin rise pattern of infarction associated with higher incidence of interatrial 
conduction delay, PR segment deviation, atrial tachycardia and atrial fibrillation on 12-h Holter 
recording than patients free of this complication. Atherosclerosis of atrial coronary arteries was 
more frequent in patients of the atrial branch occlusion group. Our study afforded a proof of 
concept that acute atrial ischemia per se promotes atrial arrhythmias in humans and supported 
the assumption that clinically silent occlusion of atrial branches might be a cause of atrial 
fibrillation in patients with chronic coronary heart disease. Moreover, technical measures to 
protect the patency of atrial coronary arteries should be implemented in patients submitted to 
percutaneous interventionism over the right or circumflex coronary arteries.             
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Table 1. Clinical characteristics of the study population. 
Patients with ABO  
(n=17)
Patients without ABO 
(n=92)
p
value
Age, years, ? (SD) 63.6 (11.8) 66.0 (10.3) 0.39 
Male, n (%) 13 (77) 72 (78) 1.00 
Smokers, n (%) 4 (24) 20 (22) 0.40 
Hypertension, n (%) 12 (71) 72 (78) 0.53 
Dyslipemia, n (%) 16 (94) 70 (76) 0.12 
Diabetes mellitus, n (%) 8 (47) 36 (39) 0.54 
Previous MI, n (%) 8 (47) 37 (40) 0.56 
Previous PTCA, n (%) 8 (47) 45 (49) 0.89 
Previous CABG, n (%) 2 (12) 9 (10) 0.68 
LVEF, %, ? (SD) 58 (12) 58 (10) 0.98 
eGFR<60mL/min/1.73m2,n(%) 2 (12) 10 (11) 1.00 
COPD or asthma, n (%) 3 (18) 6 (7) 0.15 
*List of abbreviations: ABO: atrial coronary branch occlusion; SD: standard deviation; MI: myocardial infarction; 
PTCA: percutaneous transluminal coronary angioplasty; CABG: coronary artery bypass grafting; LVEF: left 
ventricular ejection fraction; eGFR: estimated glomerular filtration rate; COPD: chronic obstructive pulmonary 
disease.   
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Table 2. Coronary angiographic and procedural characteristics. 
Patients with 
ABO  (n=17) 
Patients without 
ABO  (n=92) 
p value
AB diameter, mm, ? (SD) 1.25 (0.44) 1.41 (0.45) 0.19 
AB ostial atherosclerotic plaque, n (%) 13 (77) 21 (23) <0.001 
ACC/AHA C type, n (%) 7 (41) 27 (29) 0.33 
Diameter coronary stenosis, %, ? (SD) 89 (10) 87 (10) 0.53 
Length of coronary lesion, mm, ?  (SD) 30 (12) 29 (18) 0.83 
Bifurcation lesion, n (%) 14 (82) 37 (40) 0.001 
Predilatation, n (%) 17 (100) 87 (95) 1.00 
   Max pressure during dilatation, atm, ?  (SD) 17 (2) 17 (3) 0.37 
Cutting balloon, n (%)  6 (35) 28 (30) 0.69 
Rotational atherectomy, n (%) 1 (6) 7 (8) 1.00 
Number of stents implanted, ?   (SD) 1.8 (1.2) 1.4 (0.7) 0.21 
Characteristics of index stent    
    Length, mm, ?  (SD) 28 (9) 23 (8) 0.021 
    Diameter, mm, ?  (SD) 3.2 (0.6) 3.0 (0.5) 0.26 
    DES, n (%) 13 (77) 76 (83) 0.71 
    Platform, n (%) 
    Stainless steel 
    Cobalt-chrome 
    Platinum-chrome 
       Absorbable  
 
3 (18) 
8 (50) 
2 (13) 
3 (19) 
 
29 (32) 
42 (51) 
8 (10) 
7 (8) 
 
0.52 
    Strut diameter, μm, ? (SD) 85 (5) 84 (16) 0.80 
    Max pressure during implantation, atm, ? (SD) 16 (3) 15 (3) 0.16 
Postdilatation, n (%) 12 (71) 59 (64) 0.61 
    Max pressure during dilatation, atm, ? (SD) 19 (2) 19 (3) 0.76 
*List of abbreviations: ABO: atrial coronary branch occlusion; AB: atrial branch; SD: standard deviation; 
ACC/AHA: American College of Cardiology/American Heart Association; atm: atmosphere; DES: drug eluting 
stent; μm: micrometers. 
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Table 3. ECG findings in the study population.  
 Patientswith ABO  (n=17) 
Patients
without ABO  (n=92) 
 Baseline Post-PTCA p value Baseline Post-PTCA p value
HR, bpm, ? (SD) 68 (12) 67 (11) 0.79 63 (11) 60 (11) 0.004 
P wave duration, ms, ? (SD) 118 (13) 128 (14) 0.017 119 (15) 122 (15) 0.001 
Incident intra-atrial conduction delay, n (%) 6 (46) 12 (19) 0.031 
PR interval, ms, ? (SD) 164 (31) 167 (27) 0.67 172 (25) 178 (30) 0.005 
QRS duration, ms, ? (SD) 90 (15) 92 (17) 0.33 96 (20) 97 (20) 0.28 
QTc interval, ms, ? (SD) 405 (31) 416 (37) 0.18 416 (27) 419 (30) 0.40 
*List of abbreviations: ABO: atrial coronary branch occlusion; PTCA: percutaneous transluminal coronary angioplasty; HR: heart rate; bpm: beats per minute; 
SD: standard deviation; ms: milliseconds. 
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Table 4. Electrophysiological findings in the study population. 
 Patientswith ABO  (n=17) 
Patients
without ABO  (n=92) 
12-hours Holter study 
Averaged HR, bpm, ? (SD) 66 (9) 63 (9) 0.16 
ASDNN, ?  (SD) 48.4 (24.6) 47.5 (22.0) 0.87 
Advanced AV block, n (%) 2 (12) 1 (1) 0.11 
Premature atrial beats, ?  (SD) 99 (216) 48 (98) 0.35 
Atrial arrhythmia, n (%) 7 (41) 13 (15) 0.020 
Atrial fibrillation, n (%) 2 (12) 0 (0) 0.025 
Ventricular tachycardia, n (%) 3 (18) 5 (6) 0.076 
Averaged Holter signal analysis 
PRf-PRi, μV, ?  (SD) 12 (27) -0.3 (14) 0.004 
Pi wave voltage, μV, ?  (SD) 75 (35) 106 (46) 0.007 
*List of abbreviations: ABO: atrial coronary branch occlusion; HR: heart rate; bpm: beats per minute; SD: standard 
deviation; ASDNN: averaged standard deviation N-N; AV: auricular-ventricular; μV: microvolts. 
Figure Legends: 
Figure 1. Flow-chart of the study. *List of abbreviations: PTCA: percutaneous transluminal 
coronary angioplasty.?
Figure 2. Atrial coronary branch occlusion during elective percutaneous transluminal coronary 
angioplasty. Panel A: the arrow indicates an atrial branch (AB) emerging from the proximal 
segment of right coronary artery (RCA).  Panel B: loss of AB (\\) after the stent implantation.?
Figure 3. Time course of mean plasma levels of high-sensitivity troponin and mid-regional 
proatrial natriuretic peptide in the study population. Panel A: The ABO group showed greater 
values of plasma levels of high sensitivity Troponin T at 8-, 12-, and 24-hours than the non-ABO 
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patients. Panel B: Both groups of patients showed parallel plasma level values of mid-regional 
proAtrial Natriuretic Peptide but with higher values in the ABO group at each time point.
*Whiskers represent the standard error of the mean.?
Figure 4. Averaged signal analysis of the PR segment displacement in the 12 hours Holter 
recording in two representative cases. Panel A illustrates an example of intra-atrial conduction 
delay in a patient of the ABO group. Panel B shows an atrial fibrillation episode recorded in the 
Holter study of the same patient of ABO group. Panel C1 shows evolving PR segment deviation 
in a patient of the ABO group. Panel C2 shows the lack of evolving PR segment deviation in a 
patient of the non-ABO group. Panel D illustrates an example of change of P wave shape in a 
patient of the ABO group.
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